Hand dermatitis in adults referred for patch testing: Analysis of North American Contact Dermatitis Group Data, 2000 to 2016 - 10/03/21
, Erin M. Warshaw, MD, MS c, d, e, Amber R. Atwater, MD f, Howard I. Maibach, MD g, Kathryn A. Zug, MD h, Margo J. Reeder, MD i, Denis Sasseville, MD j, James S. Taylor, MD k, Joseph F. Fowler, MD l, Melanie D. Pratt, MD m, Anthony F. Fransway, MD n, Matthew J. Zirwas, MD o, Donald V. Belsito, MD p, James G. Marks, MD q, Vincent A. DeLeo, MD r, Joel G. DeKoven, MD sAbstract |
Background |
Hand eczema (HE) is a heterogeneous and burdensome disorder.
Objective |
To characterize the clinical characteristics, etiologies and allergen relevance in adults with HE referred for patch testing.
Methods |
Retrospective analysis (2000-2016) of North American Contact Dermatitis Group data (n = 37,113).
Results |
Overall, 10,034 patients had HE, with differences of overlap between allergic contact, irritant contact, and atopic dermatitis. Allergic contact HE fluctuated, whereas atopic HE steadily increased, and irritant HE decreased over time. HE was associated with higher proportions of positive patch tests (67.5% vs 63.8%; χ2, P < .0001). The five most common clinically relevant allergens were methylisothiazolinone, nickel, formaldehyde, quaternium-15, and fragrance mix I. HE was associated with significantly higher odds of positive patch test reactions and clinical relevance in 13 and 16 of the 25 most common allergens, respectively, including preservatives, metals, topical medications, and rubber accelerators.
Limitations |
No data on HE phenotype.
Conclusion |
HE in adults was associated with higher proportions of positive patch tests, with a heterogeneous profile of allergens. Patch testing remains an important tool in the evaluation of patients with HE.
Le texte complet de cet article est disponible en PDF.Key words : allergic contact dermatitis, arm, atopic dermatitis, contact allergy, eczema, foot, hand, irritant contact dermatitis
Abbreviations used : ACHE, ACD, AD, AHE, HE, ICD, ICHE, NACDG, SPIN
Plan
| Funding sources: None. |
|
| IRB approval status: Approved by the institutional review board of Northwestern University. |
|
| This study was supported by resources and use of facilities at the Minneapolis Veterans Affairs Medical Center. The contents do not represent the views of the U.S. Department of Veterans Affairs or the U.S. Government. |
Vol 84 - N° 4
P. 989-999 - avril 2021 Retour au numéro
Article précédent
- Scalp involvement in patients referred for patch testing: Retrospective cross-sectional analysis of North American Contact Dermatitis Group data, 1996 to 2016
- Erin M. Warshaw, Sara A. Kullberg, Joel G. DeKoven, Howard I. Maibach, Donald V. Belsito, Jonathan I. Silverberg, Joseph F. Fowler, Amber R. Atwater, Denis Sasseville, Margo J. Reeder, James S. Taylor, Vincent A. DeLeo, Melanie D. Pratt, Kathryn A. Zug, Anthony F. Fransway
- Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry
- Lieneke F.M. Ariëns, Jorien van der Schaft, Lotte S. Spekhorst, Daphne S. Bakker, Geertruida L.E. Romeijn, Tessa A. Kouwenhoven, Marijke Kamsteeg, Angelique N. Voorberg, Albert J. Oosting, Ilona de Ridder, Annemieke Sloeserwij, Inge Haeck, Judith L. Thijs, Marie L.A. Schuttelaar, Marjolein S. de Bruin-Weller
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?